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Background: In dogs, occurrence of lipid metabolism disorders such as obesity and diabetes mellitus has increased
markedly in recent years. Hyperlipidemia has been regarded as a common characteristic for obese animals and
hyperlipidemic condition may be associated with inflammation, oxidative stress and lipid composition changes.
In this study, we investigated the changes in plasma cholesterol and triglyceride (TG) profiles and metabolite
concentrations in 24 dogs (young group: 0-7 years old, n = 12, aged group: 8-13 years old, n = 12).
Results: Plasma adiponectin (ADN) concentrations were significantly lower in aged dogs than those in young dogs
(mean ± SD, 17.2 ± 10.0 μg mL-1 vs 29.3 ± 12.5 μg mL-1, respectively; P <0.05). Although there were no significant
differences statistically, aged dogs showed significantly higher plasma alpha1- acid glycoprotein (alpah1-AG) levels
compared to those in young dogs. Plasma cholesterol lipoprotein and TG lipoprotein were divided into four fractions
by biphasic agarose gel electrophoresis technique. The levels of the third TG-lipoprotein fraction from the positive
pole (TG Fraction 3) were significantly higher in aged dogs than in young dogs (mean ± SD, 143.0 ± 109.3 mg dL-1
vs 55.2 ± 31.3 mg dL-1, respectively; P <0.05). On the correlation coefficient analysis by Peason’s method, moderate
positive correlations were seen between the age and TG (r = 0.446, P = 0.029), TG Fraction 3 (r = 0.516, P = 0.010),
malondialdehyde (r = 0.146, P = 0.043), alpha-1 AG (r = 0.448, P = 0.028) levels, respectively. Moderate negative
correlations were seen the age and total cholesterol (TC) Fraction 2 (r = -0.446, P = 0.029), glucose (r = -0.637, P = 0.001),
ADN (r = -0.408, P = 0.048), respectively.
Conclusions: Present data suggest biochemical characteristics of lipid metabolism disorder may be affected by aging
in dogs.
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Hyperlipidemia has been regarded as a common charac-
teristic for obese dogs [1], and prevalence of overweight
and obese dog has been estimated as 24% to 30% [2].
Hyperlipidemic condition could be a deteriorative factor
for metabolic syndrome in dogs [3]. Physiological variables,
such as age, body weight and sex may affect hyperlipidemia
severity in dogs [4]. Effect of aging on plasma total* Correspondence: kawasumi224@nvlu.ac.jp
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has been reported by our colleagues [5]. We have to pay
much attention to lipid metabolic condition associated
with lipid oxidative stress, antioxidant and inflammation
degree, and insulin resistance in dogs with different ages.
Hyperlipidemia in aged dogs seems to be confounded by
nutrition states, inflammation, and oxidative stress as the
same as in aged human [6].
Plasma malondialdehyde (MDA) concentrations have
been regarded as a lipid peroxide stress marker [7], and
the correlation between plasma lipid peroxide levels and
high prevalence of diabetic patients has been reported inral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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peroxidase have been regarded as enzymes that increase
with oxidation stress elevation. Alpha 1-acid glycoprotein
is an acute phase protein that is produced in the liver in
response to inflammation. Excess non-esterified fatty acid
(NEFA) released from adipocytes induces lipotoxicity.
Plasma insulin and adiponectin are hormones that
suggest the degree of insulin resistance. In this study,
we investigated the changes in above mentioned plasma
parameters and cholesterol and TG profiles in 24 dogs
with different ages though we could not elucidate the daily
rhythmicity of lipid levels completely [10].
Methods
Animals
Twelve client-owned young dogs (female n = 7, male n = 5,
0-7 years old) and twelve aged dogs (female n = 7, male
n = 5, 8-13 years old) were examined. The age, breed,
sex and body weight of dogs used in the present study were
shown in Table 1. Each dog was given a meal twice a day.Table 1 Profile of the age, breed, sex and body weight
(BW) in young and aged dogs
No. Age (years old) Breed Sex BW (kg)
A
1 0 Toy poodle F 5.5
2 0 Mix M 19
3 1 Miniature pinscher M 4.5
4 2 Miniature pinscher M 4.3
5 3 Miniature dachshund F 2.8
6 3 German shepherd F 25.0
7 4 Belgian tervuren M 23.2
8 5 Miniature dachshund F 5.8
9 5 Miniature dachshund F 5.6
10 5 Pekingese F 4.4
11 7 Toy poodle M 3
12 7 Miniature schnauzer F 5.6
B
1 8 Miniature schnauzer M 6.0
2 8 Miniature dachshund M 4.3
3 8 Beagle M 16.7
4 8 Miniature dachshund F 5.5
5 8 Toy poodle F 3.9
6 9 Shih tzu M 10.0
7 9 Miniature schnauzer M 7.1
8 10 Miniature dachshund F 5.8
9 10 Miniature schnauzer F 5.6
10 12 Toy poodle F 2.72
11 13 Pomeranian F 5.3
12 13 Miniature dachshund F 4.8
A: young group (0-7 years old).
B: aged group (8-13 years old).The diet composition varied among examined dogs, since
each dog’s owner was permitted to give normal diet in this
study. All animals exhibited no clinical signs for diseases and
were not on any medication at the time of the study. They
were recommended to examine plasma biomarker levels on
lipid metabolism by veterinarians. Any clinically treated
animals were excluded from the study. The degree of obesity
in dogs was assessed by a five-level body conditioning score
(BCS) as follows [1-5]: very thin [1], underweight [2], ideal
[3], over weight [4] and obese [5], commonly used in
Japan [1]. Ethical approval was obtained from the Nippon
Veterinary and Life Science University Animal Research
Committee (No.13-92). Written informed consent was
obtained from the owners of the animals in this study.
Blood samples were taken from jugular veins of dogs
fasted overnight (without any nutrient for over 8 hours after
the last meal) in heparinized tubes. Plasma was recovered
by centrifugation at 3,000 rpm, for 15 min at 4°C in each
veterinary clinic and subsequently stored at -25°C until use.
Glucose (GLU), TC, TG, total protein (TP), blood urea
nitrogen (BUN) and creatinine (CRE) concentrations and
alanine aminotransferase (ALT), aspartate aminotransferase
(AST), alkaline phosphatase (ALP) activities were measured
using an autoanalyzer (JCA-BM2250, JEOL Ltd., Tokyo,
Japan) with the manufacture’s reagents at Monolis Inc.
(Tokyo, Japan). It took less than a week to obtain the results
of laboratory analysis.
Plasma alpha1-acid glycoprotein (alpha1-AG) concentra-
tions were measured by single radial immunodiffusion
method at Monolis Inc. Plasma NEFA and MDA concen-
trations were measured using commercial kit, NEFA-C test
(Wako Pure Chemical Industries, Inc., Tokyo, Japan), and
NWLSSTM Malondialdehyde assay (Northwest Life Science
Specialties, LLC, Vancouver, Canada), respectively. Plasma
insulin (INS) and adiponectin (ADN) concentrations were
measured with commercial ELISA kits, Lbis dog insulin kit
(SHIBAYAGI Co., Gunma, Japan), mouse/rat adiponectin
kit (Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan),
respectively. Plasma SOD activity and GSHPx activities were
measured using commercial kit, NWLSSTM Superoxide
Dismutase Activity Assay (Northwest Life Science
Specialties, LLC, Vancouver, Canada), and NWLSSTM
Glutathione Peroxidase Assay (Northwest Life Science
Specialties, LLC, Vancouver, Canada), respectively.
Plasma lipoprotein cholesterol and TG profiles were
measured by the biphasic agarose gel electrophoresis
method using commercial kit, Quickgel LIPO gels (Helena
Laboratories, Saitama, Japan) with Cho/Trig COMBO
reagents (Helena Laboratories, Saitama, Japan).
Statistical analysis
Results are presented as mean ± SD. Statistical signifi-
cance was determined by unpaired Student’s t-test. The
significance level was set at P < 0.05.
Table 2 Plasma TC, TG, lipoprotein compositions, MDA,
and NEFA concentrations in dogs with aging
0-7 years (12) 8-13 years (12)
BCS 2.8 ± 0.7 3.4 ± 0.8
TC (mg dL-1) 284.8 ± 111.2 229.3 ± 87.4
Fraction 1 (mg dL-1) 192.2 ± 47.5 175.4 ± 45.7
Fraction 2 (mg dL-1) 79.8 ± 72.6 27.4 ± 15.6 (11)*
Fraction 3 (mg dL-1) 11.7 ± 6.6 15.8 ± 14.8
Fraction 4 (mg dL-1) 3.6 ± 3.3 (4) 0 (11)*
TG (mg dL-1) 87.8 ± 68.0 160.2 ± 119.7
Fraction 1 (mg dL-1) 0 0
Fraction 2 (mg dL-1) 2.2 ± 1.7 (8) 0.5 ± 0.5 (7)*
Fraction 3 (mg dL-1) 55.2 ± 31.3 143.0 ± 109.3*
Fraction 4 (mg dL-1) 41.8 ± 36.4 (6) 47.8 ± 16.2 (4)
MDA (μm ol L-1) 4.0 ± 1.5 4.9 ± 2.2
NEFA (mEq L-1) 0.7 ± 0.3 0.9 ± 0.3
The numbers in parentheses indicate the number of animals examined.
Data are expressed as mean ± SD.
*Significant (P < 0.05) when compared against 0-7 years old group.
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parameter value was calculated by Peason’s method.
The significance level was set at P < 0.05, P < 0.01,
respectively.
Results
As shown in Table 2, BCS (mean ± SD) in young dogs
was 2.8 ± 0.7, while that in aged dogs was 3.4 ± 0.8.
Though there were no significant differences statistically,
plasma TG, MDA and NEFA levels in aged dogs were
higher than those in young dogs. Using electrophoretic
measurements, the level of the third TG-lipoprotein
fraction from the positive pole (Fraction 3) in aged
dogs was determined significantly higher than that inA: Young dog 
Figure 1 Gel electrophoresis and profiles for cholesterol lipoprotein a
zones; cholesterol lipoprotein fractions Gray zones; triglyceride lipoprotein
lipoprotein fractions are piled up.young animals. (mean ± SD, 143.0 ± 109.3 mg dL-1 vs
55.2 ± 31.3 mg dL-1, respectively; P <0.05). Representative
cholesterol lipoprotein and TG lipoprotein electrophoresis
tracing in young and aged dogs were shown in Figure 1A
and B, respectively. The biphasic agarose gel electrophoresis
technique revealed a prominent third TG-lipoprotein
fraction from the positive pole (Fraction 3) in aged dogs.
As shown in Table 3, plasma AST, ALP activities, INS
concentrations and plasma alpha1-AG levels in aged
dogs were higher than those in young animals, though
there were no significant differences. Plasma SOD activitity
in aged dogs was significantly higher than that in young
dogs (mean ± SD, 28.0 ± 13.3 U mL-1 vs 10.8 ± 2.6 U mL-1,
respectively; P <0.05). Plasma ADN concentration in aged
dogs was significantly lower than that in young dogs
(mean ± SD, 17.2 ± 10.0 μg mL-1 vs 29.3 ± 12.5 μg mL-1, re-
spectively; P < 0.05). There were no significance differences
seen in plasma GSHPx activities.
As shown in Table 4, the correlation coefficients
were calculated by Peason’s method. Moderatepositive
correlations were seen between the age and TG (r = 0.446,
P = 0.029), TG Fraction 3 (r = 0.516, P = 0.010), MDA
(r = 0.146, P = 0.043), alpha-1 AG (r = 0.448, P = 0.028)
levels, respectively. Moderate negative correlations were
seen between the age and cholesterol lipoprotein Fraction 2
(r = -0.446, P = 0.029), glucose (r = -0.637, P = 0.001), ADN
(r = -0.408, P = 0.048), respectively.
Discussion
In this study, 4 Miniature Schnauzer were included.
However, they will need to be separated from other
breeds for further study since they have genetic
problems associated with lipid metabolism. BCS in
aged dogs was higher than that in young dogs and
plasma lipid metabolic biomarker, TG, MDA, and NEFA
levels increased with aging. In addition, moderate positiveB: Aged dog
nd triglyceride lipoprotein. (A) young dog and (B) aged dog. White
fractions. Black zones; cholesterol lipoprotein fractions and triglyceride
Table 3 Plasma GLU, TP, AST, ALT, ALP, BUN, CRE, INS,
ADN, SOD, alpha1-AG concentrations in dogs with aging
0-7 years (12) 8-13 years (12)
GLU (mg dL-1) 106.7 ± 15.7 89.0 ± 12.0*
TP (g dL-1) 6.9 ± 0.5 7.3 ± 0.7
AST (IU L-1) 32.3 ± 8.5 39.1 ± 26.0
ALT (IU L-1) 51.4 ± 29.4 50.2 ± 19.6
ALP (IU L-1) 124.3 ± 64.5 (11) 230.6 ± 117.6 (10)
BUN (mg dL-1) 22.6 ± 9.8 17.7 ± 6.7
CRE (mg dL-1) 1.1 ± 0.2 1.0 ± 0.2
INS (ng mL-1) 0.9 ± 0.3 1.5 ± 1.0
ADN (μg mL-1) 29.3 ± 12.5 17.2 ± 10.0*
SOD (U mL-1) 10.8 ± 2.6 (6) 28.0 ± 13.3 (7)*
GSHPx (mU mL-1) 53.3 ± 11.6 54.8 ± 10.9 (9)
alpha1-A G (μg mL-1) 90.9 ± 77.1 172.9 ± 109.8
The numbers in parentheses indicate the number of animals examined.
Data are expressed as mean ± SD.
*Significant (P < 0.05) when compared against 0-7 years old group.
Table 4 Correlation coefficients and P value between the
age and examined parameters in 24 dogs
Correlation Coefficient P value
BCS 0.260 0.219
BW - 0.314 0.135
TC - 0.362 0.083
Fraction 1 - 0.255 0.23
Fraction 2 - 0.446 0.029*
Fraction 3 0.191 0.372
Fraction 4 - 0.054 0.803
TG 0.446 0.029
Fraction 1 - 0.014 0.95
Fraction 2 - 0.110 0.607
Fraction 3 0.516 0.010 **
Fraction 4 - 0.028 0.98
MDA 0.416 0.043*
NEFA 0 .135 0.53
GLU - 0.637 0.001 **
TP 0 .2 1 1 0.322
AST 0.162 0.449
ALT - 0.129 0.548
ALP 0.304 0.148
BUN - 0.336 0.109
RE - 0.287 0.174
INS 0 159 0.459
ADN - 0.408 0.048*
SOD 0 203 0.342
G SHPx - 0.034 0.876
alph1a- AG 0.448 0.028*
Correlation coefficients w ere caliculated by Peason's method.
*Significan celevel wass etat P < 0.05.
**Signific an c eleve l was set a t P < 0.01.
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between the age and TG, TG Fraction 3, MDA,
alpha1-AG levels, respectively, while moderate negative
correlations (correlation coefficient:-0.4- -0.7) were seen
between the age and cholesterol lipoprotein Fraction 2,
GLU, ADN levels, respectively by Peason’s analysis.
It was reported that increase in plasma TG levels was
one of characteristics indicating lipid accumulation in
the liver of animals [11]. On the contrary, plasma ADN
concentrations significantly decreased in aged dog group
with a higher mean BCS compared to the young dog
group. It was reported that adipose cells secreted
decreased amounts of ADN as lipid accumulated in
subcutaneous and visceral portion of the body [12].
Generally, plasma levels of MDA as a lipid peroxide
stress marker increase in presence of oxidative stress. It
was reported that serum MDA levels in cancer dogs
with oxidative stress were significantly higher than those
in clinically normal dogs [13]. Increase in plasma MDA
concentrations in aged dogs may indicate increase in
lipid peroxide stress in aged dogs with tendency to be
overweight. In addition, plasma MDA levels are considered
to be lipid peroxide stress marker that may suggest early
stage of lipid metabolic disorder in dogs. Plasma NEFA
levels in aged dogs were higher than those in young
dogs. It was reported that increased plasma NEFA induced
heterotopy lipid accumulation in the body and excess
β-oxidation in pancreatic β-cells, which induced reactive
oxygen species (ROS) generation [14]. Finally, excess
NEFA induced pancreatic β cell dysfunction, which
referred to as lipotoxicity [15,16]. Lipotoxicity induces
insulin resistance [17]. Plasma INS concentrations in aged
dogs were higher than those in young dogs, which maysuggest an association between lipid metabolic disorder
and insulin resistance with aging in dogs.
The activities of plasma SOD, an antioxidant, were
higher in aged dogs. It is speculated that one of reasons
that plasma antioxidant increase with aging was due to
the lipid peroxide increase with aging. In the present
study, plasma MDA levels were higher in aged dogs.
Plasma SOD levels in 6 young dogs and 7 aged dogs were
analyzed statistically, since 6 of 12 in young dogs and 5 of
12 in aged dogs had SOD levels lower than detectable
range under detection limit levels (<5 U mL-1), while
plasma GSHPx levels in 9 aged dogs were analyzed
statistically, since 3 of 12 in aged dogs indicated above
detection limit levels (> 65 mU L-1).
Plasma alpha1-AG levels in aged dogs were significantly
higher than those in young dogs. These results suggest that
inflammatory condition associated with lipid accumulation
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an important role at early stage of lipid disorder in dogs.
The third TG-lipoprotein fraction from the positive
pole (Fraction 3) in aged dogs was prominent as revealed
by the biphasic agarose gel electrophoresis technique
(Figure 1B). We think this fraction may be very low-density
lipoprotein-triglyceride. Further comparative examination
on TG lipoprotein fractions separated by electrophoresis
versus ultracentrifugation will be necessary to confirm
this point.
In our previous report [18], we proposed the new
criteria to detect canine hyperlipidemia at early stage
based on the any two of the following three factors,
namely elevated plasma triglyceride (TG) (≥165 mg dL-1),
total cholesterol (TC) (≥200 mg dL-1) and non-esterified
fatty acid (NEFA) (≥1.5 mEq L-1) levels. Based on the
criteria, 1 of 12 (8.3%) in young dogs and 4 of 12
(33.3%) in aged dogs were diagnosed as hyperlipidemia in
the present study.
Conclusions
Lipid metabolic disorder seems to be complicated by
nutrition states, inflammation, oxidative stress in dogs.
Present data suggested that these factors were affected by
aging. We should continue further examination to clarify
these relationships in order to confirm its reliability in
detecting early stage of lipid metabolic disorder in dogs.
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